Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Sponsoring Workshops To Increase Rare Disease Treatment Options
FDA is putting on workshops for drug makers in an attempt to increase their pool of applicants for approved "orphan drugs," drugs that treat rare diseases.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
